Literature DB >> 26471074

The degradation of curcuminoids in a human faecal fermentation model.

Suryani Tan1,2,3, Luca Calani4, Letizia Bresciani4, Margherita Dall'asta4, Andrea Faccini5, Mary Ann Augustin1, Sally L Gras2,3,6, Daniele Del Rio4.   

Abstract

In the present study, the colonic metabolism of three curcuminoids (80.1% curcumin, 15.6%, demethoxycurcumin (DMC) and 2.6% bis-demethoxycurcumin (Bis-DMC)) was evaluated using an in vitro model containing human faecal starters. The breakdown products formed were identified and characterized using different analytical platforms. Following in vitro incubation, the relative amounts of degraded curcuminoids and the produced metabolites were analyzed using a UHPLC coupled with a linear ion trap mass spectrometer, with the addition of hybrid ion trap-Orbitrap Mass Spectrometer when required. Up to ∼24% of curcumin, ∼61% of demethoxycurcumin (DMC) and ∼87% of bis-demethoxycurcumin (Bis-DMC) were degraded by the human faecal microbiota after 24 h of fermentation in vitro. Three main metabolites, namely tetrahydrocurcumin (THC), dihydroferulic acid (DFA) and a metabolite with an accurate mass of 181.08734, which was tentatively identified as 1-(4-Hydroxy-3-methoxyphenyl)-2-propanol were detected in the fermentation cultures containing the curcuminoids. The data presented here provide insights into curcuminoid colonic metabolism, showing that bacterial breakdown products should be considered in further studies on both bioavailability bioactivity of curcumin.

Entities:  

Keywords:  Curcumin; curcuminoids; faecal slurry; gut microbiota; metabolism

Mesh:

Substances:

Year:  2015        PMID: 26471074     DOI: 10.3109/09637486.2015.1095865

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  8 in total

1.  A Novel Triple Stage Ion Trap MS method validated for curcumin pharmacokinetics application: A comparison summary of the latest validated curcumin LC/MS methods.

Authors:  Wenji Li; Hilly Yang; Brian Buckley; Lujing Wang; Ah-Ng Kong
Journal:  J Pharm Biomed Anal       Date:  2018-04-17       Impact factor: 3.935

Review 2.  The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota.

Authors:  Małgorzata Makarewicz; Iwona Drożdż; Tomasz Tarko; Aleksandra Duda-Chodak
Journal:  Antioxidants (Basel)       Date:  2021-01-28

3.  Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects.

Authors:  Martin Purpura; Ryan P Lowery; Jacob M Wilson; Haider Mannan; Gerald Münch; Valentina Razmovski-Naumovski
Journal:  Eur J Nutr       Date:  2017-02-16       Impact factor: 5.614

Review 4.  Mutual Two-Way Interactions of Curcumin and Gut Microbiota.

Authors:  Ryszard Pluta; Sławomir Januszewski; Marzena Ułamek-Kozioł
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

Review 5.  Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.

Authors:  Yujiao Zheng; Xiaowen Gou; Lili Zhang; Hanjia Gao; Yu Wei; Xiaotong Yu; Bing Pang; Jiaxing Tian; Xiaolin Tong; Min Li
Journal:  Front Cell Infect Microbiol       Date:  2020-07-17       Impact factor: 5.293

6.  Effects of Turmeric and Curcumin Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study.

Authors:  Christine T Peterson; Alexandra R Vaughn; Vandana Sharma; Deepak Chopra; Paul J Mills; Scott N Peterson; Raja K Sivamani
Journal:  J Evid Based Integr Med       Date:  2018 Jan-Dec

Review 7.  Curcumin, Cardiometabolic Health and Dementia.

Authors:  Yoona Kim; Peter Clifton
Journal:  Int J Environ Res Public Health       Date:  2018-09-24       Impact factor: 3.390

Review 8.  Gut Microbiota as a Prospective Therapeutic Target for Curcumin: A Review of Mutual Influence.

Authors:  Wissam Zam
Journal:  J Nutr Metab       Date:  2018-12-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.